March 30 - April 2, 2020
FierceHealthcare and FiercePharma Present:
Coronavirus Virtual Series
Coronavirus Virtual Series
Free Virtual Event
About
Coverage areas include vaccine development, supply chain disruptions, diagnostic advances, payer’s role in containment, physician/provider preparedness, and technology’s role in preventing and treating outbreaks.
Agenda:
Monday, March 30
Now Available On-Demand | 11:00am-12:00pm ET | Physician/provider preparedness: How to prepare for a coronavirus outbreak within your facility
Now Available On-Demand | 1:00pm-1:30pm ET | COVID-19: Six things health organizations should consider (but may not be)
Now Available On-Demand | 3:00pm-4:00pm ET | The race to develop a vaccine for COVID-19
Tuesday, March 31
Now Available On-Demand | 11:00am-12:00pm ET | How tech will help U.S. healthcare fight coronavirus
Now Available On-Demand | 1:00pm-2:00pm ET | Crisis Consumer Outreach: Coronavirus and Beyond
Now Available On-Demand | 3:00pm-4:00pm ET | Challenge accepted: Biopharma puts COVID-19 in its pipeline
Wednesday, April 1
Now Available On-Demand | 11:00am-12:00pm ET | The critical role of payers in stopping the spread of coronavirus
Now Available On-Demand | 1:00pm-1:30pm ET | Solutions for rapid development and manufacturing responses to public health threats
Now Available On-Demand | 3:00pm-4:00pm ET | COVID-19 threatens pharma’s global supply chain. What next?
Thursday, April 2
Now Available On-Demand | 1:00pm-2:00pm ET | Cutting-edge approaches to support clinical development and evidence generation in the COVID-19 era
These virtual events are free! Click here to register now.
Agenda
Coronavirus is clearly spreading in the U.S. now and providers are on the front lines of responding. How well are facilities preparing? What should they be doing to ramp up for large numbers of patients? What solutions should they be considering for handling the influx, including the supply chain, workforce concerns, revenue impacts during potential outbreaks? Our experts take a look at the current situation and offer their insights into what providers should be considering and be proactive in their response to COVID-19.
Speakers
Gregg Miller, M.D.
Chief Medical Officer
Vituity Healthcare
Alan Kumar, M.D.
Emergency Medicine Physician
Community Hospital in Munster, IN
Laura Seng
Chairwoman of National Healthcare Department
Barnes & Thornburg
Tina Reed
Executive Editor
FierceHealthcare
Linda Ruschau
Chief Client Officer
PatientPoint
COVID-19: Six things health organizations should be considering (but might not be)
The US healthcare system could potentially be tested as a pandemic broadens, flooding its emergency rooms, intensive care units, physician offices, urgent care clinics and telehealth lines with patients suffering from the symptoms of COVID-19. Leveraging insights from PwC Health Research Institute's latest report, COVID-19: Six things health organizations should consider (but might not be), a panel of PwC health experts will examine key considerations for healthcare organizations as they make and execute their short- and long-term plans for handling the pandemic.

Speakers
Igor Belokrinitsky

James McNeil

Vitaly Glozman

Benjamin Isgur

Sarah Haflett

Speakers
Shlomi Madar, Ph.D
Shlomi Madar, Ph.D
VP Healthcare Solutions
Signals Analytics
Michael Breen
Associate Director of Infectious Diseases
GlobalData
Kizzmekia S. Corbett PhD
Research Fellow
NIH, NIAID, Vaccine Research Center
Jim Mayne, Ph.D.
Vice President, Science and Regulatory Advocacy
PhRMA
Eric von Hofe

Catherine Calarco

Eric Sagonowsky

We will examine tech’s role in containing the spread of COVID-19 and examine both business opportunities and potential headwinds caused by the virus.
Speakers
Peter Antall, M.D.

Linda Branagan, Ph.D.

Kuldeep Singh Rajput

Ann Mond Johnson

Heather Landi

Linda Ruschau
Chief Client Officer
PatientPoint
Crisis Consumer Outreach: Coronavirus and Beyond
Coronavirus (COVID-19) is top of mind throughout the United States and around the world. With rampant uncertainty, a rapid response with timely and relevant outreach can help inform consumers and safeguard their health. This roundtable will feature HMS’ Chief Medical Officer Dr. Gary Call, who has extensive experience working with Managed Care organizations, and will highlight the impact of this public health crisis as well as key considerations you can use to care for your various populations. Joining him are key members of HMS’ consumer engagement team, including Ellen Harrison, who will offer real-world strategies for incorporating crisis management into your communication plans through innovative messaging and digital technologies.
Presented by:
Speakers
Gary Call, MD

Ellen Harrison, RN

Speakers
Amirah Al Idrus

George Scangos

Zhi Hong, Ph.D.

Amanda Bosse

President, Drug Product Division North America Pharma Services
Thermo Fisher Scientific
Ann Leen, Ph.D.

Speakers
Kate Barry

Beth Leonard

Vincent Nelson, M.D.

Paige Minemyer

Solutions for rapid development and manufacturing responses to public health threats
Mounting a rapid and effective response to emerging public health threats is a continuing challenge, which will only become more important in an increasingly connected world. Critical to these responses is the ability to rapidly develop, scale and manufacture novel vaccines and therapeutics. Emergent will present how we have leveraged our development and manufacturing network and close relationships to support innovators in producing vaccines and therapeutics to respond to these challenges. Specific topics related to effective response to emerging public health threats include:
- Automation and innovation: speeding development data to support clinical trial material manufacturing
- Technology transfer: developing a flexible approach to decrease risk and time to production
- Flexible facilities: flexible development and GMP facilities to decrease time to clinic and improve ability to support platform-based approaches
- Case studies on responses to prior outbreaks

Speaker
Rick Welch
A few key questions: How much of that cost can be passed along and how much must producers assume? Should the industry rewrite its supply chain script going forward? What policies should regulators have in hand to protect drug supplies for patients? Is it time for governments to subsidize API production in their own countries to insure constant supplies or can the market sort this out? In this roundtable, experts will discuss the current challenges COVID-19 presents to the global supply chain and what improvements Big Pharma and biotech firms should make from the outbreak moving forward.
Speakers
Chris Chen

Damien Holly

Leon Wyszkowski

Kyle Blankenship


Speakers
Jaime Caro
MDCM, FRCPC, FACP

Mariah Baltezegar, MBA

Rebecca Willumson

sponsors









social feeds
What You're Saying
#FierceLondon